Elevance Health Financials

Elevance Health Inc

ELVNYSE

Trade with Public

$394.43

-4.68-1.17%

가까이에: Aug 28, 5:00 PM EST

$394.30

-0.13-0.03%

시간외: Aug 28, 4:12 PM EST

배당금: 배당락일은 11일 후입니다

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 배당금 비교 옵션 주식 보고서

Elevance Health Financials

Elevance Health (ELV) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings

Elevance Health Inc. (NYSE:ELV) reported strong Q2 results and raised full-year guidance. Analysts have adjusted price targets for ELV stock.

Avi Kapoor

Elevance Health's Small Outlook Boost Disappoints, Stock Sinks

Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a conservative guidance raise.

Vandana Singh

Earnings Scheduled For July 15, 2026

Companies Reporting Before The Bell • VCI Global (NASDAQ:VCIG) is estimated to report earnings for its Fiscal Year 2025. • PNC Financial Services Gr (NYSE:PNC) is projected to report quarterly earnings at $4.43 per

Benzinga Insights

PRO
Elevance Health Sees FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est

Elevance Health (NYSE:ELV) FY2026 EPS expected to be more than $20.10 vs $20.26 Est..

Benzinga Newsdesk

PRO
Elevance Health Sees FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est

Elevance Health (NYSE:ELV) FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est..

Benzinga Newsdesk

PRO
Elevance Health Q2 Adj. EPS $7.45 Beats $6.21 Estimate, Sales $49.826B Beat $48.693B Estimate

Elevance Health (NYSE:ELV) reported quarterly earnings of $7.45 per share which beat the analyst consensus estimate of $6.21 by 19.97 percent. This is a 15.72 percent decrease over earnings of $8.84 per share from the

Benzinga Newsdesk

Elevance Health Inc

Elevance Health Financials

Earnings & Guidance News

These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings

Elevance Health's Small Outlook Boost Disappoints, Stock Sinks

Earnings Scheduled For July 15, 2026

PRO
Elevance Health Sees FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est

PRO
Elevance Health Sees FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est

PRO
Elevance Health Q2 Adj. EPS $7.45 Beats $6.21 Estimate, Sales $49.826B Beat $48.693B Estimate

뉴스

파트너 / 기고자

벤징가 글로벌

Benzinga

Benzinga

Benzinga

Elevance Health Inc

Elevance Health Financials

Earnings & Guidance News

These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings

Elevance Health's Small Outlook Boost Disappoints, Stock Sinks

Earnings Scheduled For July 15, 2026

PROElevance Health Sees FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est

PROElevance Health Sees FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est

PROElevance Health Q2 Adj. EPS $7.45 Beats $6.21 Estimate, Sales $49.826B Beat $48.693B Estimate

Benzinga

뉴스

파트너 / 기고자

벤징가 글로벌

PRO
Elevance Health Sees FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est

PRO
Elevance Health Sees FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est

PRO
Elevance Health Q2 Adj. EPS $7.45 Beats $6.21 Estimate, Sales $49.826B Beat $48.693B Estimate